1.33

2.21% -0.03

After Hours: 1.32 -0.01 -0.75%

Opko Health Inc (OPK)

Overview News Price History Option Chain Financials Why OPK Down? Discussions Forecast

Opko Health Inc stock is traded at $1.33, with a volume of 1.97M. It is down -2.21% in the last 24 hours and down -3.62% over the past month. OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

Previous Close:

$1.36

Open:

$1.36

24h Volume:

1.97M

Relative Volume:

0.70

Market Cap:

$1.02B

Revenue:

$711.41M

Net Income/Loss:

$-133.73M

P/E Ratio:

-7.00

EPS:

-0.19

Net Cash Flow:

$-199.99M

1W Performance:

+3.91%

1M Performance:

-3.62%

6M Performance:

-1.48%

1Y Performance:

-9.52%

1-Day Range:

$1.31

$1.36

1-Week Range:

$1.27

$1.375

52-Week Range:

$1.11

$2.035

Opko Health Inc Stock (OPK) Company Profile

Name

Opko Health Inc

Sector

Healthcare (1120)

Industry

Diagnostics & Research (53)

Phone

305-575-4181

Address

4400 BISCAYNE BLVD., MIAMI, FL

Employee

2,997

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

OPK's Discussions on Twitter

Compare OPK with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
OPK Opko Health Inc	1.33	1.04B	711.41M	-133.73M	-199.99M	-0.19
TMO Thermo Fisher Scientific Inc	615.45	232.51B	43.74B	6.58B	6.11B	17.31
DHR Danaher Corp	239.00	168.37B	24.27B	3.50B	5.02B	4.8589
IDXX Idexx Laboratories Inc	724.76	56.96B	4.17B	1.03B	940.22M	12.61
A Agilent Technologies Inc	147.99	42.11B	6.95B	1.30B	1.15B	4.5696
IQV Iqvia Holdings Inc	240.86	41.28B	15.90B	1.28B	2.21B	7.2842

Opko Health Inc Stock (OPK) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-20-25	Initiated	JP Morgan	Neutral
Oct-31-25	Downgrade	Jefferies	Buy → Hold
Apr-25-25	Initiated	JP Morgan	Neutral
Jun-29-23	Upgrade	Barrington Research	Mkt Perform → Outperform
Dec-15-22	Initiated	H.C. Wainwright	Buy
Jan-24-22	Downgrade	Barrington Research	Outperform → Mkt Perform
Jun-21-21	Initiated	Ladenburg Thalmann	Buy
Nov-25-19	Initiated	Piper Jaffray	Overweight
Mar-02-18	Downgrade	JP Morgan	Neutral → Underweight
Sep-14-17	Downgrade	JP Morgan	Overweight → Neutral
Jun-21-16	Reiterated	Standpoint Research	Buy
Jun-03-16	Initiated	Standpoint Research	Buy
Mar-31-16	Reiterated	Barrington Research	Outperform
Oct-16-15	Initiated	JP Morgan	Overweight
Sep-11-15	Downgrade	Jefferies	Buy → Hold
Mar-03-15	Downgrade	Oppenheimer	Outperform → Perform
May-12-14	Reiterated	Oppenheimer	Outperform
Mar-14-14	Initiated	Oppenheimer	Outperform
Nov-13-13	Reiterated	Ladenburg Thalmann	Buy
May-30-13	Reiterated	Ladenburg Thalmann	Buy
Oct-22-12	Initiated	Barrington Research	Outperform
Dec-01-11	Reiterated	Ladenburg Thalmann	Buy
Jul-14-11	Initiated	Ladenburg Thalmann	Buy

View All

Opko Health Inc Stock (OPK) Latest News

10:01 AM

Bearish Setup: Should I hold or sell OPKO Health Inc nowWeekly Stock Summary & Reliable Entry Point Alerts - baoquankhu1.vn

10:01 AM

Jan 10, 2026

Is OPKO Health Inc. stock undervalued vs historical averagesQuarterly Trade Summary & Low Risk Investment Opportunities - ulpravda.ru

Jan 10, 2026

Jan 09, 2026

Is OPKO Health Inc. stock vulnerable to regulatory risks2025 Dividend Review & Advanced Technical Analysis Signals - ulpravda.ru

Jan 09, 2026

Is OPKO Health Inc. stock supported by innovation pipelineShare Buyback & Real-Time Chart Pattern Alerts - ulpravda.ru

Jan 09, 2026

Jan 08, 2026

Why OPKO Health Inc. stock is considered a top pick2025 Fundamental Recap & Weekly Watchlist for Hot Stocks - ulpravda.ru

Jan 08, 2026

Is OPKO Health Inc. stock attractive for income investorsQuarterly Portfolio Review & Fast Exit/Entry Strategy Plans - ulpravda.ru

Jan 08, 2026

Setup Watch: Why OPKO Health Inc. stock appeals to analystsTrade Risk Assessment & Weekly High Return Forecasts - ulpravda.ru

Jan 08, 2026

Does OPKO Health Inc. stock trade at a discount to peersJuly 2025 PreEarnings & Smart Money Movement Alerts - ulpravda.ru

Jan 08, 2026

How OPKO Health Inc. (XCY) stock trades after earningsEarnings Forecast Updates & Low Entry Cost Investments - ulpravda.ru

Jan 08, 2026

OPKO Health, Inc. (NASDAQ:OPK) insiders have recently purchased stock and their bets paid off last week as company hit US$1.0b market cap - simplywall.st

Jan 08, 2026

Clinical Laboratory Services Market is expected to reach US$ - openPR.com

Jan 08, 2026

Jan 07, 2026

Why OPKO Health Inc. stock is rated strong buyPrice Gap Trading Strategies & Free Phenomenal Capital Appreciation - bollywoodhelpline.com

Jan 07, 2026

What risks investors should watch in OPKO Health Inc. stockSector Rotation Strategies & Big Gains Small Capital - ulpravda.ru

Jan 07, 2026

OPKO Health bets on RAYALDEE and pipeline progress for 2026 growth - MSN

Jan 07, 2026

Jan 06, 2026

OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference - markets.businessinsider.com

Jan 06, 2026

OPKO Health, Inc. to Participate in 44th Annual J.P. Morgan Healthcare Conference - Quiver Quantitative

Jan 06, 2026